Ozempic maker sues Hims & Hers
Drug maker Novo Nordisk has filed a lawsuit against telehealth provider Hims and Hers over alleged copycat versions of its weight-loss and obesity medications.
Novo Nordisk
FDA to remove suicide warnings for weight loss drugs
The FDA wants suicide warnings to be taken off of some popular weight-loss medications.
Wegovy starter dose now available
People wanting to lose weight now have a cheaper option.
Eli Lily cuts price for Zepbound
A drug that helps people lose weight now has a slimmer price tag.
FDA considers weekly insulin for diabetics
A U.S. Food and Drug Administration Advisory Committee is considering the benefits of a weekly insulin shot for diabetics.
